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An Unfolded Putative Transmembrane Polypeptide,
which Can Lead to Endoplasmic Reticulum Stress,
Is a Substrate of Parkin
An autosomal recessive form of PD (AR-JP), which is
the major cause of juvenile PD, results from mutations
of the Parkin gene (Kitada et al., 1998). In AR-JP patients,
loss of the dopaminergic neurons and consequently,
parkinsonian symptoms, can occur without LB forma-
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Parkin is one of the largest genes of the human ge-Japan
2 Department of Neurology nome (1.5 Mb). It comprises twelve exons encoding a
465 amino acid protein with a molecular mass of 52Juntendo University School of Medicine
Bunkyo-ku, Tokyo, 113-0033 kDa (Kitada et al., 1998; Shimura et al., 1999). The NH2-
terminal 76 amino acids of Parkin are 62% homologousJapan
to ubiquitin. The COOH-terminal half of Parkin contains
two RING fingers flanking a cysteine-rich domain, termed
in between RING fingers (IBR) (Morett and Bork, 1999).Summary
Several studies have recently revealed that numerous
proteins with RING finger motifs have ubiquitin-proteinA putative G protein-coupled transmembrane poly-
peptide, named Pael receptor, was identified as an ligase (E3) activity (Jackson et al., 2000; Joazeiro and
Weissman, 2000). We and others have demonstratedinteracting protein with Parkin, a gene product respon-
sible for autosomal recessive juvenile Parkinsonism that Parkin is an E3 and that AR-JP-linked Parkin mu-
tants are defective in E3 activity (Imai et al., 2000; Shi-(AR-JP). When overexpressed in cells, this receptor
tends to become unfolded, insoluble, and ubiquiti- mura et al., 2000; Zhang et al., 2000).
Proteins fated to degrade in the proteasomes are sub-nated in vivo. The insoluble Pael receptor leads to
unfolded protein-induced cell death. Parkin specifi- ject to covalent modification by ubiquitin as a small
protein tag. Ubiquitination proceeds through a sequen-cally ubiquitinates this receptor in the presence of
ubiquitin-conjugating enzymes resident in the endo- tial enzymatic reaction composed of ubiquitin-activating
enzyme (E1), ubiquitin conjugating enzyme (E2), and E3plasmic reticulum and promotes the degradation of
insoluble Pael receptor, resulting in suppression of the (Hershko and Ciechanover, 1998; Hochstrasser, 1996).
The exquisite specificity for the proteins to be ubiquiti-cell death induced by Pael receptor overexpression.
Moreover, the insoluble form of Pael receptor accumu- nated is usually determined by a diverse family of E3s
with a specific E2. Because AR-JP is caused by a losslates in the brains of AR-JP patients. Here, we show
that the unfolded Pael receptor is a substrate of Parkin, of functional Parkin, the accumulation of Parkin sub-
strate(s) should lead to dopaminergic neuronal death.the accumulation of which may cause selective neu-
ronal death in AR-JP. We found that overexpression of Parkin confers resis-
tance to endoplasmic reticulum (ER) stress induced by
the unfolded protein in dopaminergic neuroblastomaIntroduction
cells, suggesting that the substrate(s) of Parkin is an
unfolded ER protein (Imai et al., 2000).The second most common neurodegenerative disease,
Parkinson’s disease (PD), is a movement disorder patho- Here, we show that a putative G protein-coupled inte-
gral membrane polypeptide, named Pael receptor, is alogically characterized by the loss of dopaminergic neu-
rons in the substantia nigra pars compacta. The etiology substrate of Parkin, and that the accumulation of Pael-R
might lead to dopaminergic neuronal death in AR-JP.of PD is still unknown, but the recent identification of
mutations in familial cases of PD has advanced under-
standing of the molecular mechanisms of this neurologi- Results
cal disease.
Two rare missense mutations in the -synuclein Identification of Parkin-Interacting Protein
(-SYN) gene (A53T and A30P) cause autosomal domi- To identify a substrate(s) of Parkin, we performed yeast
nant familial PD (Kruger et al., 1998; Polymeropoulos et two-hybrid screening of human adult brain cDNA librar-
al., 1997). -SYN is a presynaptic protein and a major ies using full-length Parkin as bait. A BLAST search
component of heavily ubiquitinated cytoplasmic aggre- revealed that one of the isolated clones from 8.5  106
gates called Lewy bodies (LBs) that are pathological library transformants encoded a partial clone (position
hallmarks of both sporadic and a subgroup of familial 314 to termination) of a homolog of endothelin receptor
PD (Trojanowski et al., 1998). LBs frequently observed type B, renamed Pael (Parkin-associated endothelin re-
in degenerating neurons, including dopaminergic neu- ceptor-like) receptor (Donohue et al., 1998; Marazziti et
rons in the substantia nigra, are currently strongly sug- al., 1997; Zeng et al., 1997).
gested to be involved in the pathogenesis of PD (Baba To examine the interaction of Pael receptor (Pael-R)
et al., 1998; Goldberg and Lansbury, 2000; Spillantini et with Parkin in mammalian cells, expression plasmids for
al., 1998). C-terminal FLAG-tagged Pael-R (Pael-R-FLAG), or its
related polypeptides (endothelin receptor type A and B
[ETA- and ETB-R]) with a FLAG tag were transiently3 Correspondence: ryosuke@brain.riken.go.jp
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Figure 1. Parkin Associates with Pael Recep-
tor (Pael-R) but Not Its Mutants
(A) Interaction of Parkin with Pael-R. Lysates
from 293T cells transfected with an empty
vector (Control), FLAG-tagged Pael-R (Pael-
R-FLAG), FLAG-tagged endothelin receptor
type A or B (ETA-R- or ETB-R-FLAG), and
Parkin were immunoprecipitated (IP) with
anti-Parkin polyclonal Abs. Immunoprecipi-
tates (IP) and total soluble lysates (Total ly-
sate) were analyzed by Western blotting
(WB).
(B) Interaction of Pael-R with Parkin and its
mutants. Lysates from 293T cells transfected
with Hemagglutinin (HA)-tagged Pael-R and
an empty vector (Control), FLAG-tagged Par-
kin (Wild-type), Parkin-N, Parkin-C, Q311X or
RING were immunoprecipitated with an
anti-FLAG mAb (FLAG-IP), then Western blot-
ted (WB). The lower panel on the right dia-
grammatically represents Parkin and the mu-
tants used to determine the Pael-R binding
domain. Numbers in parentheses indicate
corresponding amino acid residues of Parkin.
An asterisk (“*”) indicates the site of a point
mutation. Ubl, ubiquitin-like domain; RING,
RING-finger motif; and IBR, in between RING
finger.
(C) Endogenous interaction of Parkin with
Pael-R in brain tissue and cultured cells. Hu-
man brain or neuroblastoma SH-SY5Y cells
were lysed as described in Experimental Pro-
cedures, then the supernatant fractions were
immunoprecipitated (IP) with preimmune sera
(C) or anti-Parkin (P) polyclonal Abs. The co-
precipitated Pael-R was detected by Western
blotting (WB) using anti-Pael-R mAb. Asterisk
indicates about 120 kDa of anti-Pael-R-
immunoreactive band, which is often ob-
served in vivo and thought to represent an
uncharacterized state of Pael-R.
transfected with a plasmid for human Parkin in human endogenous Parkin and Pael-R in dopaminergic neuro-
blastoma SH-SY5Y cells and human brain tissues, bothembryonic kidney 293T cells. Pael-R-FLAG was specifi-
cally, and ETB-R-FLAG was marginally, coimmunopreci- of which express Pael-R mRNA (see Figure 7C). As
shown in Figure 1C, Pael-R immunoreative protein waspitated with Parkin by anti-Parkin antibodies (Abs) (Fig-
ure 1A). When Pael-R or ETB-R, but not control or ETA-R coimmunoprecipitaed with endogenous Parkin.
The observation that Pael-R expressed in culturedwas overexpressed in 293T cells, these proteins mi-
grated as high molecular mass broad smears on West- cells is liable to migrate slowly in Western blots (as
shown in Figure 1A) prompted us to examine whetherern blots, suggesting covalent modifications, including
glycosylation and ubiquitination. In addition, Pael-R- Pael-R can be covalently modified by ubiquitin. Overex-
pressed ubiquitin with HA-tag (HA-Ub) was coexpressedand ETB-R-expressing cells were dead (40% and 20%
of the transfected cells, respectively; data not shown), with FLAG-tagged Pael-R in 293T cells, then immuno-
precipitated with an anti-FLAG mAb. The immunopre-resulting in the low expression level of Parkin (Figure
1A, lower panels). Next, we examined which region of cipitated Pael-R was covalently modified by HA-Ub, and
even in the absence of HA-Ub, higher molecular-shiftedParkin binds to Pael-R in mammalian cells (Figure 1B).
A series of Parkin mutants and a wild-type protein with Pael-R band was detected by an anti-Ub mAb (Figure 2).
These are likely to represent the difficulty of the normalFLAG-tag was coexpressed and coimmunoprecipitated
with Pael-R tagged with HA (hemagglutinin) at its C folding of Pael-R polypeptide, and polypeptides with
abnormal conformations may be degraded by ubiquitin/terminus in 293T cells. Only the C-terminal portion of
Parkin (Parkin-C; 217–465 aa) and full-length Parkin, but proteasome pathway.
not a variety of Parkin proteins harboring mutations in
their C-terminal part, retained full binding activity to Parkin Interacts with ER-Associated E2s
We reported that Parkin is upregulated by unfolded pro-Pael-R, indicating that the complete C-terminal struc-
ture is indispensable for binding to Pael-R. tein stress and that it suppresses cell death induced by
unfolded protein stress (Imai et al., 2000). In responseFinally, we tested physiological interactions between
ER Stress Leads to Juvenile Parkinson’s Disease
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Figure 2. Pael-R Tends to Be Ubiquitinated
Vector plasmid (Control) or Pael-R-FLAG cDNA combined with
empty vector () or HA-Ub construct () was transfected into SH-
SY5Y cells. Immunoprecipitates with anti-FLAG mAb (FLAG-IP) and
total soluble lysates (Total lysate) were analyzed by Western blotting
using anti-FLAG, -HA or -Ub Ab.
Figure 3. Parkin Associates with UBC6 and UBC7
Vector plasmid or FLAG-Parkin cDNA combined with an empty vec-to stress in the ER, the unfolded protein response (UPR)
tor (), constructs of Myc-tagged-UBC6, -UBC7, -UBCH6, or -E2-that regulates the expression of a series of genes, in-
25K was transfected into 293T cells. Immunoprecipitates with anti-cluding ER-associated protein degradation (ERAD)-
FLAG mAb (FLAG-IP) and soluble total lysates (Total lysate) wererelated genes, is induced (Travers et al., 2000). The ERAD
analyzed by Western blotting (WB) using anti-FLAG, or anti-Myc Ab.
system eliminates misfolded ER proteins including inte-
gral membrane and secretory proteins via degradation
in the cytosol (Plemper and Wolf, 1999). ERAD sub- We found that the fraction of Parkin-immunoprecipitates
promoted the ubiquitination reaction of Pael-R muchstrates are retrotranslocated across the ER membrane
into the cytosol, where they are ubiquitinated and de- more remarkably than whole-cell extract alone (Figure
4A). It is noted that the fraction of Parkin-immunoprecipi-graded through the ubiquitin-proteasome pathway in
cooperation with UBC6, UBC7, the proteasome com- tates was sufficient for this reaction despite the absence
of purified E2 (Figure 4A, lanes 6 and 7). These resultsplex, and other components (Biederer et al., 1997; Bor-
dallo et al., 1998; Gilon et al., 2000; Wilhovsky et al., imply that Parkin immunopurified from the cells medi-
ates transfer of ubiquitin from cellular E2(s), which might2000). As our data has provided evidence that Parkin,
an apparent RING-type E3 upregulated by UPR, could form a complex with Parkin, to Pael-R. To examine this
possibility, we used a recombinant protein consistingbe involved in ERAD, we tested whether Parkin can bind
to ER-associated E2s. Human 293T cells were tran- of Parkin with glutathione S-transferase (GST-Parkin) or
of a disease-associated exon 4 deletion mutant of Parkinsiently transfected with plasmids for various E2s with a
Myc-tag in the presence or absence of FLAG-Parkin (GST-E4) as an E3 ubiquitin-ligase. Because Pael-R
may be an integral membrane polypeptide, and becausecDNA, then coimmunoprecipitated. The results revealed
that Parkin interacts with ER-associated UBC6 and 7, de novo synthesized Pael-R with abnormal conforma-
tions may be subject to ERAD, the recombinant E2s webut not with negative controls (UBCH6 and E2-25K) in
vivo (Figure 3). tested in this assay were UBC6 (or UBC6C; 1–288 aa)
and UBC7 in addition to UBCH7, which can function as
an E2 for Parkin in vitro. The results presented in FigurePael-R Is a Substrate of Parkin
Then, we evaluated whether Parkin ubiquitinates Pael-R 4B demonstrate that GST-Parkin substantially promoted
the ubiquitination of Pael-R despite the absence of thewith ER-associated E2s by an in vitro ubiquitination
assay. To reconstitute the ubiquitin conjugation reaction E2s (Figure 4B, lane 4), suggesting that endogenous
E2(s) interacting with the Pael-R produced in reticulo-of Pael-R, we added Parkin immunopurified from SH-
SY5Y cells or whole-cell extract of SH-SY5Y cells to the cyte lysates was copurified. In contrast, a deletion mu-
tant of recombinant Parkin, GST-E4 failed to ubiquiti-reaction assay in the presence of purified Ub and E1.
Cell
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Figure 4. Pael-R Can Be a Substrate for Parkin
(A) In vitro ubiquitination assay of Pael-R using endogenous Parkin from cultured cells. 35S-labeled Pael-R-FLAG was incubated in the presence
of Ub, E1 with the following components: WCE, whole cell extracts of SH-SY5Y; Mock-IP, immunoprecipitates with preimmune sera from SH-
SY5Y cells; Parkin-IP, immunoprecipitates with anti-Parkin Ab from SH-SY5Y cells. Input and “–” indicate Pael-R at time 0 and Pael-R incubated
with Ub and E1 alone for 90 min, respectively.
(B) In vitro ubiquitination assay using recombinant Parkin and E2s. The labeled Pael-R as in (A) was reacted with Ub and E1 in the presence
or absence () of the indicated recombinant E2 (H7, UBCH7; 6/7, UBC6C and 7) together with GST-fused Parkin or GST-fused exon 4-deleted
mutant of Parkin (E4). Asterisks indicate that active cysteine of E2s was exchanged to serine residues.
(C) In vitro ubiquitination assay using Pael-R and its homolog as substrates. The labeled Pael-R, ETB-R, or ETBR-LP-2 (LP-2) was reacted in
the presence of UBC6C and 7 as in (B).
(D) SH-SY5Y cells transfected with a construct for Pael-R-FLAG combined with an empty vector (Control) or a plasmid for Parkin were
incubated with or without 10 M lactacystin, then pulse-labeled with 35S-methionine/cysteine and chased for the indicated periods in the
presence (Lc ) or absence (Lc ) of 10 M lactacystin. 35S-labeled Pael-R was immunoprecipitated, detected by autoradiography (left), then
quantified by phosphorimaging. Levels of labeled Pael-R are plotted relative to the amount present at time 0 (right).
nate Pael-R even in the presence of the E2s (Figure 4B, Parkin accelerates Pael-R degradation via the ubiquitin/
proteasome pathway, Pael-R turnover was analyzed inlanes 1–3, 7, and 8). The combination of UBC6C, UBC7,
and GST-Parkin remarkably accelerated ubiquitination, the presence or absence of Parkin by pulse-chase ex-
periments (Figure 4D). Following a 180 min chase in thewhereas catalytic inactive mutants of both UBC6C and
7 reduced ubiquitination to the basal level (Figure 4B, absence of lactacystin, 18% of de novo synthesized
Pael-R remained in the control cells. Lactacystin decel-compare lanes 4, 9, and 10). The conjugation reaction
by a combination of recombinant UBC6 (or UBC6C)/ erated the rate of Pael-R degradation in control cells
and in those transfected with Parkin, resulting in 54%UBC7 and GST-Parkin was highly specific for Pael-R,
but not for ETB-R or ETBR-LP-2, which are very closely and 58% of protein remaining at 180 min of chase, re-
spectively. In contrast, Pael-R degradation in the Parkin-related to Pael-R (Valdenaire et al., 1998) (Figure 4C).
Together with the binding between Parkin and UBC6/7 transfected cells was considerably accelerated, such
that 0.8% of the protein remained at 180 min. These(Figure 3), this in vitro ubiquitination assay suggests that
UBC6 and UBC7 are involved along with Parkin in the results indicated that Parkin is involved in Pael-R degra-
dation through the ubiquitin/proteasome pathway.Pael-R degradation pathway. To investigate whether
ER Stress Leads to Juvenile Parkinson’s Disease
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Unfolded Protein-Stress Promotes the Insolubility 5B). About 20% of transfected cells underwent cell
death under these conditions (Figures 5B and 5C). Lac-of Pael-R
When Pael-R was overexpressed in cultured cells even tacystin (20 M) for 16 hr did not affect SH-SY5Y cell
death compared with nontreated mock-transfectedin the absence of the proteasome inhibitors, the Pael-R
is heavily ubiquitinated (Figure 2). This finding is reminis- cells, whereas the UPR-inducers, tunicamycin (5 g/ml)
and 2-ME (2 mM), induced death in about 40% of allcent of that of polyubiquitinated cystic fibrosis trans-
membrane conductance regulator (CFTR) or  opioid mock-transfected cells. Under the same conditions,
about 50% of Pael-R-overexpressing cells were deadreceptors. The majority (75% and 60%, respectively) of
de novo synthesized CFTR and  opioid receptors failed in the presence of lactacystin (Figures 5B and 5C). Like-
wise, about 60% were killed by tunicamycin or 2-MEto fold correctly (Jensen et al., 1995; Petaja-Repo et al.,
2001; Ward et al., 1995). Such proteins are retrotrans- (Figure 5B). To further confirm the involvement of un-
folded protein stress in cell death induced by overex-ported from the ER to the cytosol via the translocon
complex including Sec61 (a specific ER transport chan- pressed Pael-R, we examined the subcellular distribu-
tion of Pael-R in the presence or absence of lactacystinnel) (Plemper and Wolf, 1999). These are subsequently
processed through ERAD that is dependent upon cyto- (Figure 5D). SH-SY5Y cells transfected with a plasmid
encoding Pael-R were incubated with or without lacta-solic ubiquitin-proteasome system.
As exposing cells to proteasome inhibitors causes cystin, then stained with anti-Pael-R or anti-BiP Ab.
Pael-R was mainly expressed on the cell surface of non-accumulation of nonionic detergent-insoluble CFTR
molecules, which are highly polyubiquitinated in vivo, treated SH-SY5Y cells, as reported, and partially in the
perinuclear positions (arrows) or the cytoplasm, sug-we examined whether Pael-R exists in the detergent
insoluble fraction in addition to detergent soluble frac- gesting that it is a plasma membrane protein. In contrast,
incubation with lactacystin for 6 hr promoted Pael-Rtion. Figure 5A shows that SH-SY5Y cells were trans-
fected with or without Pael-R cDNA, and 1% Triton accumulation in the ER, inhibiting the expression on the
cell surface. Pael-R localization in the ER was confirmedX-100-soluble and -insoluble fractions were subjected to
Western blot analysis. The amount of Pael-R-immunore- by costaining with anti-BiP, as well as with pDsRed-ER,
which is a plasmid encoding a red fluorescent proteinactive material in the insoluble fraction of the control
sample was comparable to that in the soluble fraction with an ER-targeting sequence (data not shown). Its
specific localization in the ER but not the Golgi waseven with no treatment. Moreover, lactacystin and UPR-
inducing reagents such as tunicamycin (an inhibitor of further confirmed by costaining with a red fluorescent
protein with a Golgi-targeting sequence (DsRed-Golgi)N-glycosylation) or 2-ME (a reducing agent) promoted
the insolubility of this polypeptide with a high molecular- or rhodamine-labeled wheat germ agglutinin (data not
shown). The results were the same in cells incubatedshifted modification. Tunicamycin caused an apparent
low molecular-mass mobility shift of Pael-R in the solu- with tunicamycin or 2-ME (data not shown). In fact, fur-
ther incubation with these reagents for up to 8–16 hrble fraction, suggesting that N-glycosylation of Pael-R
was inhibited. We recovered the insoluble Pael-R from resulted in formation of aggresome-like inclusions at the
juxtanuclear site (Kopito, 2000). At this stage, cell bodiesinsoluble fractions of the same samples, then analyzed
them using anti-Ub polyclonal Abs (Figure 5A, right). In were small and round, ready to undergo cell death (Fig-
ure 5E). Together with the results of the Western blottinggood correlation with the accumulation of Pael-R in the
insoluble fractions, high molecular weight material re- analysis above, these immunocytochemical studies
supported the notion that the accumulation in the ER ofacted with the Ub Abs in the insoluble Pael-R-immuno-
precipitated fractions. In contrast, little of such material overexpressed Pael-R leads to unfolded protein-induced
ER stress as indicated by BiP upregulation, finally caus-was detected in the nontreated sample. We also noted
that lactacystin and the UPR-inducing reagents added ing cell death (Kozutsumi et al., 1988).
during Pael-R overexpression in cells also upregulated
the ER-chaperone, BiP (GRP78) and endogenous Parkin Parkin Suppresses the Accumulation of Pael-R
in the soluble fractions, and that these proteins accumu- and Subsequent Cell Death
lated to some extent in the insoluble fractions (Figure Because of the protective function of Parkin against
5A). These results are in agreement with our previous unfolded protein-induced cell death, we anticipated that
findings that UPR inducers upregulate Parkin and BiP Parkin also rescues cells from overexpressed Pael-R-
(Imai et al., 2000). induced death. Thus, we transfected SH-SY5Y cells with
vector plasmid or Pael-R cDNA combined with cDNAs
for a series of FLAG-tagged Parkin and its mutants.Accumulation of Pael-R Induces Cell Death
As mentioned above, overexpression of Pael-R specifi- Lysates from these transfected cells were separated
into 1% Triton X-100-soluble and -insoluble fractions,cally induces cell death. One possible cause of cell death
in the presence of overexpressed Pael-R is a disrupted immunoprecipitated with an anti-FLAG mAb, and then
Western blotted (Figure 6A). Consistent with the obser-intracellular signal transduction, including apoptotic
pathways. Another possibility is cell death by unfolded vations in Figure 1, soluble Pael-R-immunoreactive
bands were specifically detected in the immunoprecipi-protein stress. The latter is likely because Pael-R was
often highly ubiquitinated (Figure 2), and because insolu- tates of Parkin, Parkin-C and, partially, T240R point mu-
tant from the soluble fraction. Another attempt to con-ble Pael-R accumulated when BiP was upregulated (Fig-
ure 5A). To test this hypothesis, we assessed the effect firm the association in the insoluble fraction revealed
that Parkin, Parkin-C and, partially, T240R still interactedof proteasome inhibitor or UPR-inducing reagents on
cell death induced by Pael-R-overexpression (Figure with Pael-R in the insoluble fraction. The coprecipitated
Cell
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Figure 5. Pael-R-Induced Unfolded Protein Stress
(A) Pael-R is easily unfolded and rendered insoluble by ER stresses. SH-SY5Y cells were transfected with empty vector () or Pael-R () for
20 hr. Cells were then incubated with or without lactacystin (10 M), tunicamycin (1 g/ml), or 2-ME (1 mM) for 16 hr. The cells were lysed
in 1% Triton X-100- containing buffer and fractionated as described (Ward et al., 1995). Each fraction was subsequently Western blotted
using antibodies against the indicated proteins. Insoluble Pael-R was immunoprecipitated from insoluble fractions of the same samples as
described in Experimental Procedures, and analyzed with anti-Ub polyclonal Abs (upper panel on the right).
(B) SH-SY5Y cells transfected with an empty vector () or Pael-R () together with a plasmid for enhanced GFP (EGFP) were incubated with
or without (non), lactacystin (Lc, 20 M), tunicamycin (Tm, 5 g/ml), or 2-ME (2 mM) for 16 hr. The count of cell death was performed as
described (Imai et al., 2000). Error bars represent standard deviation (SD) calculated from triplicate samples.
(C) Morphology of dead Pael-R-expressing cells. SH-SY5Y cells transfected with Pael-R were incubated with or without lactacystin as in (B).
Cells expressing Pael-R were visualized using anti-Pael-R mAb (green) and by counterstaining the cell nucleus with 4, 6-diamidino-2-
phenylindole (DAPI, blue). Dying cells with a condensed nucleus and expressing Pael-R are indicated by arrowheads.
(D) Immunolocalization of overexpressed Pael-R in SH-SY5Y cells. SH-SY5Y cells transfected with Pael-R were incubated with (middle and
lower panels) or without (upper panels) lactacystin (20 M) for 6 hr. Pael-R-expressing cells were visualized with anti-Pael-R mAb (green),
and by counterstaining ER and Golgi (red) with anti-BiP and DsRed-Golgi, respectively. Colocalization of Pael-R with ER, but not Golgi shows
yellow field with a complete match. Arrows indicate the perinuclear accumulation of Pael-R.
(E) Cytoplasmic inclusion of Pael-R. SH-SY5Y cells transfected with Pael-R were treated with 20 M lactacystin for the indicated periods.
Cellular localization of Pael-R was visualized using anti-Pael-R Ab (green). The perinuclear inclusion of Pael-R is indicated with arrowheads.
ER Stress Leads to Juvenile Parkinson’s Disease
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Figure 6. Parkin Suppresses Unfolded Pael-R-Induced Cell Death
(A) Parkin suppresses accumulation of insoluble Pael-R in the cells. SH-SY5Y cells transfected with vector plasmid () or construct for Pael-
R-HA () combined with construct for mock (Control), FLAG-Parkin (Wild-type), -E4, -T240R, or -Parkin-C, were lysed and separated into
1% Triton X-100-soluble (S) or -insoluble (I) fractions, then immunoprecipitated with anti-FLAG mAb (IP). Coprecipitated Pael-R was detected
by Western blotting (WB) with anti-HA mAb. Polyubiquitinated Pael-R, which was confirmed by Western blotting on the same membranes
with anti-Ub mAb (data not shown), indicates Ubn-Pael-R.
(B) Expression constructs as in (A) were cotransfected into SH-SY5Y cells together with a plasmid for EGFP as an indicator gene for 48 hr.
The count of cell death was performed as described in the legend for Figure 5B.
Pael-R-immunoreactive material with FLAG-Parkin and Parkin-C coexpression, respectively, whereas the cell
death was not suppressed by E4 (Figure 6B). Theseits mutants from the insoluble fraction included high
molecular-shifted smeared bands, indicating modifica- findings indicated that intact Parkin, but not its mutants,
promotes proteasomal degradation of Pael-R before thetion by polyubiquitination (Figure 6A). The amount of
insoluble Pael-R in the total insoluble fraction was signif- receptor accumulates in the insoluble fractions.
icantly reduced in the presence (compared with the ab-
sence) of Parkin. In contrast, the disappearance of insol- Accumulation of Pael-R in AR-JP Brain
Based on the results described above, specific dopa-uble Pael-R was partially or completely suppressed in
the presence T240R and Parkin-C, or E4, respectively. minergic neuronal death in AR-JP is most likely caused
by the accumulation of the Parkin substrate, Pael-R. ToIn agreement with these data on insoluble Pael-R, cell
death induced by overexpressed Pael-R was signifi- obtain evidence supporting this idea, we assessed the
amount of endogenous Pael-R in the human brain. Thecantly and partially alleviated by Parkin and T240R or
Cell
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Figure 7. Pael-R in Brains of Patients with AR-JP
(A) Human tissues of frontal lobe cortex from normal or AR-JP brains, SH-SY5Y, or 293T cells were separated into 1% Triton X-100-soluble
or -insoluble fractions, then immunoprecipitated (IP) with isotype-matched control IgG (mouse IgG2b, C) or anti-Pael-R mAb (clone 1, P). Each
fraction was, subsequently, immunoprecipitated with anti-GluR4 mAb. Precipitates were examined by Western blotting with another anti-
ER Stress Leads to Juvenile Parkinson’s Disease
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frontal lobe cortices from 4 patients with AR-JP and 2 We prepared an anti-Pael-R Ab, which recognized
mouse and human Pael-R, but not its homolog LP-2control individuals were homogenized and separated
into 1% Triton X-100-soluble or -insoluble fractions. The (Figure7D), ETA-R, or ETB-R (data not shown). Immuno-
histochemical studies showed that Pael-R was widelyfractions were then immunoprecipitated using a Pael-R
mAb or a control mAb. Then, the amount of immuno- expressed in the brain, including the substantia nigra
(Figure 7E). Most of the Pael-R-positive cells were 2,precipited Pael-R was normalized by that of glutamate
receptor 4 (GluR4) (Figure 7A). Pael-R was immunopre- 3-cyclic nucleotide 3-phosphodiesterase (CNPase)-
immunoreactive oligodendrocytes (Figures 7I and K). Oncipitated from the control soluble fractions, and from the
soluble AR-JP samples, with an insignificant variance the other hand, most of neuronal nuclei (NeuN)-positive
cells were Pael-R-negative or weak positive (Figure 7J).between 0.4- to 1.0-fold compared to a control sample
(Normal 1). In contrast, 12- to 35-fold Pael-R-immunore- However, tyrosine hydroxylase-immunoreactive cells
were largely Pael-R-positive, indicating that dopaminer-active material was detected in the insoluble faction of
AR-JP compared to Normal 1. Both fractions prepared gic neurons in the zona compacta of the substantia
nigra belong to an exceptional subpopulation of neuronsfrom SH-SY5Y cells and 293T cells, in which the expres-
sion of Parkin mRNA but not Pael-R mRNA was detected expressing Pael-R (Figures 7E–7H).
(Figure 7C), were likewise analyzed. The same band was
detected in Pael-R-immunoprecipitates of the soluble Discussion
fraction from SH-SY5Y cells, but not from those of 293T
cells, confirming the specificity of anti-Pael-R mAb. We In this study, we identified and characterized a putative
seventh transmembrane protein, termed Pael-R, whichcould hardly recover Pael-R-immunoreactive material
from the insoluble fraction of SH-SY5Y cells as well interacts with Parkin. We concluded that this protein is
an authentic in vivo substrate of Parkin from the follow-as from non-AR-JP human brain, suggesting that the
normal expression level of Pael-R does not lead to the ing evidence: First, Parkin is likely to be involved in
ERAD since it is upregulated along with BiP during UPRinsoluble accumulation of Pael-R. Furthermore, in both
normal and AR-JP brain tissues, ubiquitinated Pael-R and it specifically binds to the ER-resident E2s, UBC6,
and UBC7. Second, Pael-R is specifically ubiquitinatedwas undetectable by Pael-R-immunoprecipitation fol-
lowed by Western blotting with anti-Ub Ab (data not through the Parkin-dependent ubiquitination pathway
in vitro in the presence of UBC6 and UBC7. Third, theshown).
Given that the lack of Parkin led to Pael-R accumula- degradation of Pael-R is promoted when it is cooverex-
pressed with Parkin in cells. Finally, Pael-R protein istion, we investigated the relationship between the accu-
mulation of Pael-R and the resultant UPR (Figure 7B). accumulated in the detergent-insoluble fraction of AR-
JP brain.The total soluble and insoluble fractions of the control
and AR-JP brain tissues were Western blotted using Recent findings have led to models of ER-membrane
dislocation coupled to the ubiquitin-proteasome path-anti-BiP polyclonal Abs. BiP was upregulated in the sol-
uble fraction of most AR-JP brain tissues compared way (Plemper and Wolf, 1999). Pael-R accumulated in
the ER at the early stage of the proteasome blockadewith controls. Moreover, BiP was also detected in the
insoluble fraction from most AR-JP brain tissues, indi- in agreement with some reports suggesting that protea-
somes function in driving the extraction of retrogradecating that UPR is induced in the AR-JP brain and that
the insoluble fraction contains unfolded ER proteins with proteins from the ER during ERAD (Figure 5D) (Mayer
et al., 1998; Yu and Kopito, 1999). In contrast, at the latewhich BiP may associate. Western blotting using anti-
neuron-specific enolase (NSE), anti-UCH-L1 and anti- stage of inhibition, the morphology of most cells was
apoptotic, being round, shriveled, and forming cyto-actin Abs showed that the amount of protein derived
from neurons and other glial cells in the brain tissues plasmic aggregations (Figure 5E). Taking into account
that ubiquitination and the proteasomal degradation ofwas similar.
We confirmed whether or not Pael-R is expressed ERAD are cytoplasmic events for which dislocation of
unfolded proteins from the ER is prerequisite, the cyto-in dopaminergic neurons in the zona compacta of the
substantia nigra, which selectively degenerate in PD. plasmic aggregation of Pael-R would correspond to the
Pael-R (clone 7) or anti-GluR4 mAb. The anti-Pael-R-precipitated materials were quantified using Quantity One software (BioRAD), and
normalized against anti-GluR4-immunoreactive materials for each lane.
(B) Twenty and ten g of the total protein from soluble and insoluble fractions, respectively, were analyzed by Western blotting. The ER stress
response was estimated by the BiP expression level, and total cellular protein concentrations in each sample were confirmed by comparison
with amounts of neuron-specific enolase (NSE), UCH-L1, and actin.
(C) Reverse transcription (RT)-PCR of total RNA isolated from SH-SY5Y and 293T cells. First strand cDNA was synthesized by RT, amplified
by PCR using various specific primers, and analyzed on a 1% agarose gel. M, 100 bp ladder marker.
(D) Specificity of anti-Pael-R Ab. The extracts of mouse (mouse), human Pael-R with FLAG-tag (human) or ETB-LP-2 with FLAG-tag (LP-2)
overexpessing 293T cells were Western blotted with anti-FLAG (left) or anti-Pael-R (right).
(E–H) Immunolocalization of Pael-R (E, green) and tyrosine hydroxylase (F, red) in a coronal section of the murine brain. Yellow indicates the
expression of Pael-R (green) in tyrosine hydroxylase-positive neurons (red) in the zona compacta of the substantia nigra (G and H). Original
magnification, 40 (E–G) or 400 (H).
(I–K) Pael-R is mainly expressed in the oligodendrocytes in the brain. (I and K) Yellow indicates the expression of Pael-R (green) in CNPase-
positive cells (red) in a serial section in (E)–(H). (J and K) Immunolocalization of Pael-R (green) and NeuN (red in J) or CNPase (red in K) in the
cerebral cortex. Original magnification, 40 (I) or 100 (J and K).
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ubiquitinated insoluble form of Pael-R detected by West- however, might suggest that unfolded protein-induced
ern blotting (Figure 5A). Based on the results obtained ER stress contributes to the degeneration of the sub-
from cultured cell experiments, Parkin seems to prevent stantia nigra in the mice. This tissue seems especially
the cytoplasmic aggregation of dislocated Pael-R and sensitive to the unfolded protein stress when the ERAD
subsequent cell death, participating in the degradation or ER quality control system is disturbed.
pathway. Moreover, Parkin may promote the retro- Taken together, we provided strong evidence that ac-
translocation of Pael-R from the ER to suppress ER cumulation of unfolded Pael-R is causative in AR-JP.
stress in cooperation with translocon complex and pro- Recently, the accumulation of denatured proteins is im-
teasome complex. plicated in many neurodegenerative diseases, including
One of the pathological hallmarks of AR-JP is the amyotrophic lateral sclerosis, Alzheimer’s disease, Par-
absence of Lewy bodies, which is well explained by the kinson’s disease, and polyglutamine disease (Julien,
hypothesis that accumulation of Pael-R is causative in 2001; Sherman and Goldberg, 2001). Emerging patho-
AR-JP. The putative membrane polypeptide Pael-R is logical and biochemical evidence obtained from the
apparently retained in the ER by a proteasome inhibitor, studies of these diseases has elicited common patho-
lactacystin, or by UPR-inducible reagents, suggesting genic mechanisms involving disturbances of the ubiqui-
that folding of Pael-R is inefficient. When the amount of tin-proteasome pathway and molecular chaperones.
unfolded proteins in the ER becomes too large to con- AR-JP can now be added to this list of the neurodegen-
trol, the cells respond by UPR that transactivates multi- erative diseases associated with accumulation of un-
ple genes including molecular chaperones and ERAD- folded proteins.
associated molecules, at least in yeast (Casagrande et
al., 2000; Friedlander et al., 2000; Travers et al., 2000). Experimental Procedures
The capacity of the ER to deal with unfolded proteins,
Plasmids, Antibodies, Proteins, and Cultured Cellshowever, might be rather small and the ER seems to
Expression plasmids for human Parkin, its mutants, UBCH6, UBCH7,have specific apoptotic pathways against ER stresses
and Ub are described elsewhere (Imai et al., 2000). Full-length
such as the disruption of intraluminal calcium homeosta- cDNAs of human and mouse Pael-R, human ETBR-LP-2, human
sis or accumulation of unfolded ER-proteins (Nakagawa UBC6 and 7, and E2-25K were cloned by reverse transcription and
et al., 2000; Urano et al., 2000). Therefore, ER stress- polymerase chain reaction (RT-PCR). ETA-R and ETB-R cDNAs were
obtained from the RIKEN Gene Bank. Recombinant GST-Parkin,induced neuronal death would occur without aggre-
GST-Ex 4, His6-tagged UBC6 and UBC7 were produced in the E.gates. Similarly, individuals afflicted with AR-JP might
coli strain BL21(DE3)pLysS (Novagen). Site-directed mutagenesisdevelop disease when accumulation of Pael-R in the
of the active cysteine of UBC6 and 7 was achieved by PCR. TheER induces cell death through ER-specific apoptotic
deletion form of the putative membrane integrated region of UBC6
pathway without cytoplasmic aggregate formation. (UBC6C; 1–288 aa) was used in the ubiquitination assay in vitro,
The tissue distribution of Pael-R is also consistent because UBC6C gave better expression in bacteria and was func-
with the dopaminergic neuron-selective degeneration tionally superior. Anti-Parkin mAbs were raised against recombinant
His6-tagged human Parkin protein produced in bacteria. Anti-humanobserved in AR-JP. Messenger RNA for Pael-R is highly
Pael R mAbs were raised against 293T cells overexpressing humanexpressed in the central nervous system. Within the
Pael-R. Anti-Myc (9E10), anti-HA (Y-11), anti-Ub (FL-76), anti-BiPbrain, Pael-R mRNA is particularly abundant in the cor-
(N-20), and anti-actin (C-2) Abs were purchased from Santa Cruz
pus callosum and the substantia nigra (Zeng et al., 1997; Biotech. Anti-FLAG (M2), anti-HA (3F10), anti-Ub (1B3), anti-GluR4
Donohue et al., 1998). In this study, we have examined (AB1508), and anti-NSE (BBS/NC/VI-H14) were obtained from
immunohistochemical localization of Pael-R in mouse Sigma, Roche Diagnostics, MBL (Nagoya, Japan), Chemicon, and
Dako, respectively. Anti-UCH-L1 Ab was a kind gift from K. Wadabrain using antiserum that very specifically recognizes
(National Institute of Neuroscience, Japan). Human embryonic kid-Pael-R (Figure 7D). Most of the Pael-R immunoreactive
ney 293T and neuroblastoma SH-SY5Y cells were transfected, andcells were CNPase-positive, oligodendrocytes of fiber
used for immunoprecipitation, Western blots, immunocytochemis-tracts. On the other hand, Pael-R also localized to a
try, and the cell death assay as described elsewhere (Imai et al.,
limited subpopulation of neurons including the dopa- 2000).
minergic neurons in the substantia nigra, hippocampal
neurons in the CA3 region, and cerebellar Purkinje cells Yeast Two-Hybrid Screening
(Figure 7 and data not shown). Assuming that neurons Plasmid pGBT9 (Clontech) harboring cDNA for full-length human
Parkin was generated as a bait for library screening. Yeast two-are more vulnerable to ER stress than oligodendrocytes,
hybrid screening was performed against a mixture of cDNA librariesselective degeneration of dopaminergic neurons in AR-
of human adult whole brain in pACT2 (purchased from Clontech)JP can be partly explained by this unique tissue expres-
and human substantia nigra in pGAD424 (prepared in our laboratory)sion of Pael-R. Although the reason why dopaminergic
using a Matchmaker Two-Hybrid System kit according to the manu-
neurons are specifically affected among the Pael-R-expres- facturer’s protocol (Clontech).
sion neurons is not clear, it could be that the expression
level of Pael-R in neurons of the substantia nigra is Immunopurification and Western Blot Analysis
significantly high, as implicated by Northern analyses Cells were suspended in lysis buffer (20 mM HEPES [pH 7.4], con-
(Zeng et al., 1997; Donohue et al., 1998). Very recently, taining 120 mM NaCl, 5 mM EDTA, 10% glycerol, and 1% Triton
X-100 with complete protease inhibitors [Roche Diagnostics]), andZuscik et al. have reported that the substantia nigra as
lysed for 30 min at 4	C. Human brain tissues of the frontal cortexwell as other areas in the brains of transgenic mice
were suspended in lysis buffer and then disrupted using a Dounceoverexpressing 1B-adrenergic receptor (1BAR), which homogenizer. The detergent-soluble/insoluble fractionation and the
is also a G protein-coupled receptor, degenerate, show- subsequent immunoprecipitation were modified from the methods
ing PD-like symptoms (Zuscik et al., 2000). A blockade described (Ward et al., 1995). The suspensions were fractionated
of 1AR signal transduction partially rescues the symp- by centrifugation at 15,000 g for 30 min. The supernatants from the
1% Triton X-100-soluble fraction were directly immunoprecipitated.toms. The insufficient rescue of the PD-like symptoms,
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The insoluble pellet fractions were washed four times with ice-cold RNA was confirmed by comparison with mRNA of the housekeeping

-actin gene.lysis buffer, and then solubilized in SDS (final concentration 1%) for
1 hr at 60	C. Ten volumes of lysis buffer with 10 mM MgCl2 and 25
g/ml of DNase I were added, then the samples were incubated for Acknowledgments
10 min at 37	C. After centrifugation at 15,000  g for 30 min, the
supernatants from 1% Triton X-100-insoluble fractions were immu- We thank H. Matsumine for his contribution to the initial phase of
noprecipitated with various Abs and protein G-coupled or protein this study, K. Wada for the anti-UCH-L1 Ab, H. Mori, Y. Mizutani
A/G (50/50%)-coupled Sepharose beads (Amersham-Pharmacia), and K. Yamane for the samples of AR-JP patients, and T. Usami for
then washed four times in lysis buffer without protease inhibitors. technical assistance. We also thank T. Okamoto for critical review
Immunoprecipitates or total cell extracts from 1% Triton X-100- of the manuscript.
soluble or -insoluble fractions were Western blotted using ECL de- This work was funded by research grants from RIKEN BSI, a Grant-
tection reagents (Amersham-Pharmacia). Protein was quantified us- in-Aid for Scientific Research on Priority Areas from the Ministry of
ing the Coomassie protein assay reagent (Pierce). Education, Culture, Sports, Science and Technology, Japan, a
Grant-in-Aid for Encouragement of Young Scientists from the Japan
Society for the Promotion of Science and grants from the MinistryImmunochemical Studies
of Health and Welfare, Japan.For immunocytochemistry, SH-SY5Y cells on 8-well chamber slides
were transfected with 1 g/well of vector for human Pael-R with or
Received April 10, 2001; revised June 5, 2001.without 0.3 g/well of expression vector for red fluorescent protein
(pDsRed1-N1, Clontech) with an ER-targeting sequence of calre-
ticulin or a Golgi-targeting sequence from human 
1, 4-galactosyl- References
transferase. After a 20 hr incubation, the cells were incubated with
or without 20 M lactacystin for 16 hr. The cells were washed with Baba, M., Nakajo, S., Tu, P.H., Tomita, T., Nakaya, K., Lee, V.M.,
PBS, fixed with 0.2% glutaraldehyde and 2% formaldehyde, then Trojanowski, J.Q., and Iwatsubo, T. (1998). Aggregation of alpha-
stained with anti-human Pael-R or anti-BiP Ab. For immunohisto- synuclein in Lewy bodies of sporadic Parkinson’s disease and de-
chemistry, the C-terminal part of mouse Pael-R (541–600 aa) was mentia with Lewy bodies. Am. J. Pathol. 152, 879–884.
produced as GST-fusion protein in E. coli. Anti-Pael-R polyclonal
Biederer, T., Volkwein, C., and Sommer, T. (1997). Role of Cue1p
Ab was raised against the GST-removed recombinant protein. The
in ubiquitination and degradation at the ER surface. Science 278,
14 m frozen sections of the C57BL/6 mouse brains were stained
1806–1809.
using anti-Pael-R (1:200 dilution), anti-TH mAb (Chemicon, 1:100),
Bordallo, J., Plemper, R.K., Finger, A., and Wolf, D.H. (1998). Der3p/anti-NeuN (Chemicon, 1:200), or anti-CNPase (Sigma, 1:100). Pri-
Hrd1p is required for endoplasmic reticulum-associated degrada-mary antibodies were localized by secondary Abs conjugated to
tion of misfolded lumenal and integral membrane proteins. Mol. Biol.Alexa 488 or 546 (Molecular Probes). Stained cells or sections were
Cell 9, 209–222.mounted in SlowFade (Molecular Probes), then analyzed with a laser
scanning confocal microscope system (Fluoview, Olympus). Casagrande, R., Stern, P., Diehn, M., Shamu, C., Osario, M., Zuniga,
M., Brown, P.O., and Ploegh, H. (2000). Degradation of proteins from
the ER of S. cerevisiae requires an intact unfolded protein responsePulse-Chase Experiment
pathway. Mol. Cell 5, 729–735.SH-SY5Y cells were transfected with vector expressing the Pael-R
Donohue, P.J., Shapira, H., Mantey, S.A., Hampton, L.L., Jensen,with a C-terminal FLAG-tag (Pael-R-FLAG) with or without plasmid
R.T., and Battey, J.F. (1998). A human gene encodes a putative Gfor Parkin, and 36 hr later, the cells were starved for 1 hr in methio-
protein-coupled receptor highly expressed in the central nervousnine/cysteine-free DMEM (M/C-free DMEM) containing 5% fetal calf
system. Brain Res. Mol. Brain Res. 54, 152–160.serum (FCS) with or without 10 M lactacystin, then labeled for 30
min at 37	C with 200 Ci/ml 35S-methionine/cysteine in M/C-free Friedlander, R., Jarosch, E., Urban, J., Volkwein, C., and Sommer, T.
DMEM with 5% FCS with or without 10 M lactacystin. Cells were (2000). A regulatory link between ER-associated protein degradation
then washed and incubated with DMEM plus 10% FCS with or and the unfolded-protein response. Nat. Cell Biol. 2, 379–384.
without 10 M lactacystin for the indicated periods. At each time Gilon, T., Chomsky, O., and Kulka, R.G. (2000). Degradation signals
point of the chase, cell lysates were immunoprecipitated with anti- recognized by the Ubc6p-Ubc7p ubiquitin-conjugating enzyme pair.
FLAG M2 affinity gel (Sigma), resolved by SDS-PAGE, and visualized Mol. Cell. Biol. 20, 7214–7219.
using an imaging analyzer (BAS-5000; Fujifilm). Metabolically la-
Goldberg, M.S., and Lansbury, P.T. (2000). Is there a cause-and-beled Pael-R was quantified using Image Gauge software (Fujifilm).
effect relationship between alpha-synuclein fibrillization and Parkin-
son’s disease? Nat. Cell Biol. 2, E115–119.
In Vitro Ubiquitination Assay
Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu.35S-labeled Pael-R-FLAG was produced by TNT quick-coupled tran-
Rev. Biochem. 67, 425–479.
scription/translation systems (Promega) with or without canine pan-
Hochstrasser, M. (1996). Ubiquitin-dependent protein degradation.creatic microsomal membranes (Promega), then immunopurified us-
Annu. Rev. Genet. 30, 405–439.ing anti-FLAG affinity gel. While both Pael-Rs produced in the
presence or the absence of the microsomal membranes work indis- Imai, Y., Soda, M., and Takahashi, R. (2000). Parkin suppresses
tinguishably in ubiquitination assays in vitro, Pael-R produced with- unfolded protein stress-induced cell death through its E3 ubiquitin-
out the microsomal membranes was used in most assays. In vitro protein ligase activity. J. Biol. Chem. 275, 35661–35664.
ubiquitination assay was performed as described elsewhere except Jackson, P.K., Eldridge, A.G., Freed, E., Furstenthal, L., Hsu, J.Y.,
for Ub (Sigma, 167 pmol) (Imai et al., 2000). Kaiser, B.K., and Reimann, J.D. (2000). The lore of the RINGs: sub-
strate recognition and catalysis by ubiquitin ligases. Trends. Cell
Biol. 10, 429–439.RT-PCR
Total RNA was isolated using ISOGEN reagent (Nippon Gene, Japan Jensen, T.J., Loo, M.A., Pind, S., Williams, D.B., Goldberg, A.L.,
Toyama). First strand cDNA was synthesized using 5 g of total and Riordan, J.R. (1995). Multiple proteolytic systems, including the
RNA by a SuperScript First Strand Synthesis kit (GIBCO-BRL). The proteasome, contribute to CFTR processing. Cell 83, 129–135.
oligo-dT primed cDNA was then amplified by PCR using the follow- Joazeiro, C.A., and Weissman, A.M. (2000). RING finger proteins:
ing primers: Pael-R forward primer, 5-CCTCCAGCTCTTCCTTC mediators of ubiquitin ligase activity. Cell 102, 549–552.
AGA-3; Pael-R reverse primer, 5-TTTCTGCCGGAGCTCGGCCA-3;
Julien, J. (2001). Amyotrophic lateral sclerosis: unfolding the toxicityParkin forward primer, 5-GGAGGCGACGACCCCAGAAAC-3; Par-
of the misfolded. Cell 104, 581–591.kin reverse primer, 5-GGGACAGCCAGCCACACAAGG-3; 
-actin
forward primer, 5-CAAGGCCAACCGCGAGAAGA-3; and 
-actin Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y.,
Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998).reverse primer, 5-GGAAGGCTGGAAGAGTGCCT-3. The quality of
Cell
902
Mutations in the parkin gene cause autosomal recessive juvenile Ward, C.L., Omura, S., and Kopito, R.R. (1995). Degradation of CFTR
by the ubiquitin-proteasome pathway. Cell 83, 121–127.parkinsonism. Nature 392, 605–608.
Wilhovsky, S., Gardner, R., and Hampton, R. (2000). HRD gene de-Kopito, R.R. (2000). Aggresomes, inclusion bodies and protein ag-
pendence of endoplasmic reticulum-associated degradation. Mol.gregation. Trends. Cell Biol. 10, 524–530.
Biol. Cell 11, 1697–1708.Kozutsumi, Y., Segal, M., Normington, K., Gething, M.J., and Sam-
Yu, H., and Kopito, R.R. (1999). The role of multiubiquitination inbrook, J. (1988). The presence of malfolded proteins in the endoplas-
dislocation and degradation of the alpha subunit of the T cell antigenmic reticulum signals the induction of glucose-regulated proteins.
receptor. J. Biol. Chem. 274, 36852–36858.Nature 332, 462–464.
Zeng, Z., Su, K., Kyaw, H., and Li, Y. (1997). A novel endothelinKru¨ger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S.,
receptor type-B-like gene enriched in the brain. Biochem. Biophys.Przuntek, H., Epplen, J.T., Schols, L., and Riess, O. (1998). Ala30Pro
Res. Commun. 233, 559–567.mutation in the gene encoding alpha-synuclein in Parkinson’s dis-
Zhang, Y., Gao, J., Chung, K.K., Huang, H., Dawson, V.L., andease. Nat. Genet. 18, 106–108.
Dawson, T.M. (2000). Parkin functions as an E2-dependent ubiquitin-Mayer, T.U., Braun, T., and Jentsch, S. (1998). Role of the protea-
protein ligase and promotes the degradation of the synaptic vesicle-some in membrane extraction of a short-lived ER-transmembrane
associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA 97, 13354–protein. EMBO J. 17, 3251–3257.
13359.
Mizuno, Y., Hattori, N., and Matsumine, H. (1998). Neurochemical
Zuscik, M.J., Sands, S., Ross, S.A., Waugh, D.J., Gaivin, R.J., Mori-and neurogenetic correlates of Parkinson’s disease. J. Neurochem.
lak, D., and Perez, D.M. (2000). Overexpression of the 1B-adrenergic71, 893–902.
receptor causes apoptotic neurodegeneration: multiple system atro-
Morett, E., and Bork, P. (1999). A novel transactivation domain in phy. Nat. Med. 6, 1388–1394.
parkin. Trends. Biochem. Sci. 24, 229–231.
Nakagawa, T., Zhu, H., Morishima, N., Li, E., Xu, J., Yankner, B.A.,
and Yuan, J. (2000). Caspase-12 mediates endoplasmic-reticulum-
specific apoptosis and cytotoxicity by amyloid-beta. Nature 403,
98–103.
Petaja-Repo, U.E., Hogue, M., Laperriere, A., Bhalla, S., Walker,
P., and Bouvier, M. (2001). Newly synthesized human delta opioid
receptors retained in the endoplasmic reticulum are retrotranslo-
cated to the cytosol, deglycosylated, ubiquitinated, and degraded
by the proteasome. J. Biol. Chem. 276, 4416–4423.
Plemper, R.K., and Wolf, D.H. (1999). Retrograde protein transloca-
tion: ERADication of secretory proteins in health and disease.
Trends. Biochem. Sci. 24, 266–270.
Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A.,
Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997).
Mutation in the alpha-synuclein gene identified in families with Par-
kinson’s disease. Science 276, 2045–2047.
Sherman, M.Y., and Goldberg, A.L. (2001). Cellular defenses against
unfolded proteins: a cell biologist thinks about neurodegenerative
diseases. Neuron 29, 15–32.
Shimura, H., Hattori, N., Kubo, S., Yoshikawa, M., Kitada, T., Mat-
sumine, H., Asakawa, S., Minoshima, S., Yamamura, Y., Shimizu,
N., and Mizuno, Y. (1999). Immunohistochemical and subcellular
localization of Parkin protein: absence of protein in autosomal reces-
sive juvenile parkinsonism patients. Ann. Neurol. 45, 668–672.
Shimura, H., Hattori, N., Kubo, S., Mizuno, Y., Asakawa, S., Mino-
shima, S., Shimizu, N., Iwai, K., Chiba, T., Tanaka, K., and Suzuki,
T. (2000). Familial Parkinson disease gene product, parkin, is a ubi-
quitin-protein ligase. Nat. Genet. 25, 302–305.
Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M., and
Goedert, M. (1998). alpha-Synuclein in filamentous inclusions of
Lewy bodies from Parkinson’s disease and dementia with lewy bod-
ies. Proc. Natl. Acad. Sci. USA 95, 6469–6473.
Travers, K.J., Patil, C.K., Wodicka, L., Lockhart, D.J., Weissman,
J.S., and Walter, P. (2000). Functional and genomic analyses reveal
an essential coordination between the unfolded protein response
and ER-associated degradation. Cell 101, 249–258.
Trojanowski, J.Q., Goedert, M., Iwatsubo, T., and Lee, V.M. (1998).
Fatal attractions: abnormal protein aggregation and neuron death
in Parkinson’s disease and Lewy body dementia. Cell Death Differ.
5, 832–837.
Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding,
H.P., and Ron, D. (2000). Coupling of stress in the ER to activation
of JNK protein kinases by transmembrane protein kinase IRE1. Sci-
ence 287, 664–666.
Valdenaire, O., Giller, T., Breu, V., Ardati, A., Schweizer, A., and
Richards, J.G. (1998). A new family of orphan G protein-coupled
receptors predominantly expressed in the brain. FEBS Lett. 424,
193–196.
